Vitrolife Dividends and Buybacks
Dividend criteria checks 0/6
Vitrolife is a dividend paying company with a current yield of 0.46%.
Key information
0.5%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | 0.7% |
| Dividend Growth | -11.4% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | SEK 1.000 |
| Payout ratio | -4% |
Recent dividend and buyback updates
Recent updates
Is Vitrolife (STO:VITR) A Risky Investment?
Nov 27
Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)
Aug 21Vitrolife AB (publ) Just Beat EPS By 16%: Here's What Analysts Think Will Happen Next
Jul 20Vitrolife AB (publ) (STO:VITR) Shares Fly 32% But Investors Aren't Buying For Growth
Jul 18Vitrolife (STO:VITR) Is Carrying A Fair Bit Of Debt
Apr 03A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)
Mar 07Vitrolife AB (publ) Just Missed Earnings; Here's What Analysts Are Forecasting Now
Feb 05Vitrolife AB (publ)'s (STO:VITR) Share Price Matching Investor Opinion
Jan 05Here's Why We Think Vitrolife (STO:VITR) Is Well Worth Watching
Dec 15Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)
Nov 27Is Vitrolife (STO:VITR) A Risky Investment?
Nov 06An Intrinsic Calculation For Vitrolife AB (publ) (STO:VITR) Suggests It's 27% Undervalued
Aug 25Vitrolife (STO:VITR) Could Easily Take On More Debt
Aug 03Are Vitrolife AB (publ) (STO:VITR) Investors Paying Above The Intrinsic Value?
May 26Is Vitrolife (STO:VITR) A Risky Investment?
Jan 23Vitrolife (STO:VITR) Seems To Use Debt Quite Sensibly
Oct 18Calculating The Fair Value Of Vitrolife AB (publ) (STO:VITR)
Sep 09Is Vitrolife (STO:VITR) A Risky Investment?
Jul 07A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)
May 26Vitrolife (STO:VITR) Seems To Use Debt Rather Sparingly
Mar 31Estimating The Fair Value Of Vitrolife AB (publ) (STO:VITR)
Feb 07Stability and Growth of Payments
Fetching dividends data
Stable Dividend: VITR is not paying a notable dividend for the Swedish market, therefore no need to check if payments are stable.
Growing Dividend: VITR is not paying a notable dividend for the Swedish market, therefore no need to check if payments are increasing.
Dividend Yield vs Market
| Vitrolife Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (VITR) | 0.5% |
| Market Bottom 25% (SE) | 1.6% |
| Market Top 25% (SE) | 5.0% |
| Industry Average (Biotechs) | 1.6% |
| Analyst forecast (VITR) (up to 3 years) | 0.7% |
Notable Dividend: VITR's dividend (0.46%) isn’t notable compared to the bottom 25% of dividend payers in the Swedish market (1.62%).
High Dividend: VITR's dividend (0.46%) is low compared to the top 25% of dividend payers in the Swedish market (4.98%).
Earnings Payout to Shareholders
Earnings Coverage: VITR is not paying a notable dividend for the Swedish market.
Cash Payout to Shareholders
Cash Flow Coverage: VITR is not paying a notable dividend for the Swedish market.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 16:19 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Vitrolife AB (publ) is covered by 11 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Erik Cassel | ABG Sundal Collier Sponsored |
| null null | ABG Sundal Collier Sponsored |
| Kallum Titchmarsh | BofA Global Research |